Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?

Launched by LOVISENBERG DIAKONALE HOSPITAL · Aug 29, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at two types of shoulder surgeries called reverse shoulder replacements to see which one helps patients get better results. One type is the conventional reverse shoulder replacement, and the other is a newer approach known as the lateralized reverse shoulder replacement. The goal is to find out if patients who receive the lateralized version have better function and recovery after two years compared to those who have the conventional procedure.

To participate in this trial, you need to be eligible for this type of shoulder surgery due to conditions like shoulder arthritis or a significant tear in your rotator cuff. You should also be able to read or write in Norwegian. However, if you have certain health issues, such as severe bone loss, dementia, or a recent shoulder fracture, you may not qualify. If you join the study, you can expect to receive one of the two surgeries and be monitored for your progress over the next two years. This research could help improve shoulder surgery outcomes for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Eligible for primary RSA due to OA, massive RC tear, failed RC repair or post-instability osteoarthritis
• • Able to read or write Norwegian
• Exclusion Criteria:
• • Severe osteoporosis
• • Osteonecrosis of the humeral head
• • Dementia
• • Poor deltoid function
• • Revision surgery
• • ASA IV
• • Suspected chronic infection
• • Acute fracture